Investigation of Otelixizumab in New-Onset, Autoimmune Type 1 Diabetes Mellitus Patients
Clinical trial NCT02000817 · COMPLETED
Trial details
- NCT number
- NCT02000817
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-12
- Primary completion
- 2018-09-27
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.